These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 29137702)

  • 1. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VOC breath biomarkers in lung cancer.
    Saalberg Y; Wolff M
    Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile organic compounds in exhaled breath: a promising approach for accurate differentiation of lung adenocarcinoma and squamous cell carcinoma.
    Li X; Shi L; Long Y; Wang C; Qian C; Li W; Tian Y; Duan Y
    J Breath Res; 2024 Aug; 18(4):. PubMed ID: 39019071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
    Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
    Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
    Sun X; Shao K; Wang T
    Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled breath condensate biomarkers for lung cancer.
    Campanella A; De Summa S; Tommasi S
    J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath carbonyl compounds as biomarkers of lung cancer.
    Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
    Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
    Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
    J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer biomarkers in exhaled breath.
    Amann A; Corradi M; Mazzone P; Mutti A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile signature for the early diagnosis of lung cancer.
    Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
    J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile organic compounds in cancer and exhaled breath detection technology.
    Zhou X; Qi M; Tang M; Wen S; Xue Z; Wang T
    Adv Clin Chem; 2024; 122():53-114. PubMed ID: 39111965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time ultrasensitive VUV-PIMS detection of representative endogenous volatile markers in cancers.
    Li Z; Shu J; Zhang P; Sun W; Yang B; Zhang H
    Cancer Biomark; 2016; 16(3):477-87. PubMed ID: 27062705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
    Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
    J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
    Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
    Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.